Intercept Pharmaceuticals
Why Robinhood?
You can watch ICPT and buy or sell other stocks, ETFs, and their options commission-free!About ICPT
Intercept Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics in treating chronic liver diseases. Its product pipeline includes Ocaliva, which is used for the treatment of biliary cholangitis, non-alcoholic steatohepatitis, sclerosing cholangitis and biliary atresia.
ICPT Key Statistics
Stock Snapshot
As of today, Intercept Pharmaceuticals(ICPT) shares are valued at $19.00. The company's market cap stands at 794.69M, with a P/E ratio of -13.58.
Intercept Pharmaceuticals(ICPT) stock opened on 2026-04-01 at —. The price climbed to — and dipped to —.
The Intercept Pharmaceuticals(ICPT)'s current trading volume is 0, compared to an average daily volume of 841.73K.
In the last year, Intercept Pharmaceuticals(ICPT) shares hit a 52-week high of $21.86 and a 52-week low of $8.82.
In the last year, Intercept Pharmaceuticals(ICPT) shares hit a 52-week high of $21.86 and a 52-week low of $8.82.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.